# Bedaquiline Fumarate Tablets 100mg (サチュロ錠１００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6222007F1023). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6222007F1023
- **Product name (Japanese):** サチュロ錠１００ｍｇ
- **English title:** Bedaquiline Fumarate Tablets 100mg
- **Active ingredient:** ベダキリンフマル酸塩
- **Active ingredient (INN):** Bedaquiline Fumarate
- **Strength / unit:** １００ｍｇ１錠
- **Route:** Oral (内用薬)
- **Therapeutic category:** 62 Chemotherapeutics (化学療法剤) › 622 Antituberculous agents (抗結核剤)
- **Manufacturer:** Janssen Pharmaceutical (ヤンセンファーマ)
- **NHI price (reference only):** JPY 21636.5 per １００ｍｇ１錠
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6222007F1023
- **JSON:** https://www.nifujipharma.com/api/drugs/6222007F1023

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Bedaquiline%20Fumarate%20Tablets%20100mg%20(%E3%82%B5%E3%83%81%E3%83%A5%E3%83%AD%E9%8C%A0%EF%BC%91%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%206222007F1023#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.